期刊文献+

Trim22 B细胞表位预测及多克隆抗体制备与鉴定 被引量:4

Prediction of the B cell epitope of Trim22 and preparation of polyclonal antibodies
下载PDF
导出
摘要 目的:预测人Trim22的B细胞抗原表位,制备并鉴定其多克隆抗体。方法:利用生物信息学软件分析Trim22的氨基酸序列,确定抗原表位并人工合成多肽。将合成肽与牛血清白蛋白(BSA)偶联,免疫大白兔制备抗Trim22的抗体。经饱和硫酸铵沉淀法纯化抗体,并对抗体进行ELISA、Western blot鉴定。结果:获得抗Trim22的多克隆抗体,抗体效价为1∶16 000,该抗体能特异性地识别包含(382~397)区段的Trim22缺失突变体,同时该抗体不能识别Trim22旁系同源分子Trim5α、Trim6和Trim34α。结论:采用人工合成多肽作为半抗原制备出抗Trim22的多克隆抗体,对研究内源性Trim22与HIV-1衣壳蛋白的相互作用机制具有重要价值。 Objective:To predict the B cell epitope of human Trim22 so as to preparte and identify polyclonal antibody induced by synthesized peptides.Methods:B cell dominant epitopes of Trim22 were predicted by the method of secondary structure,hydrophilicity,antigenicity,accessibility and flexibility.The synthesized peptides were cross-linked with bovine serum album(BSA),which was used to immunize rabbits.The polyclonal antibodies were purified by saturated ammonium sulfate,and then they were characterized by ELISA and Western blot.Results:The polyclonal antibodies against Trim22 were prepared successfully,with the titer of 1∶16 000.Western blot identified that the antibodies could recognize Trim22 truncation mutant containing the sequence of 382-397,whereas the antibodies could not recognize the Trim22 paralogous molecules,such as Trim5α,Trim6 and Trim34α.Conclusion:The synthesized peptides for Trim22 can be used to immunize rabbits to generate the polyclonal antibodies successfully.It will be propitious for the intensive study of the interactions between endogenous Trim22 and HIV-1 Gag protein.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2011年第10期917-921,共5页 Chinese Journal of Immunology
基金 滨州医学院科研启动基金项目(BY2010KYQD07)资助
关键词 三基序蛋白22 表位预测 多肽抗体 Trim22 Epitope prediction Peptide antibodies
  • 相关文献

参考文献13

  • 1Ozato K,Shin D M,Chang T H et al.TRIM family proteins and their emerging roles in innate immunity[J].Nat Rev Immunol,2008;8(11):849-860.
  • 2McNab F W,Rajsbaum R,Stoye J P et al.Tripartite-motif proteins and innate immune regulation[J].Curr Opin Immunol,2010;23(1):46-56.
  • 3Carthagena L,Bergamaschi A,Luna J M et al.Human TRIM gene expression in response to interferons[J].PLoS One,2009;4(3):e4894.
  • 4Barr S D,Smiley J R,Bushman F D.The interferon response inhibits HIV particle production by induction of TRIM22[J].PLoS Pathog,2008;4(2):e10000072.
  • 5Nisole S,Stoye J P,Saib A.TRIM family proteins:retroviral restriction and antiviral defence[J].Nat Rev Microbiol,2005;3(10):799-808.
  • 6Stremlau M,Owens C M,Perron M J et al.The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys[J].Nature,2004;427(6977):848-853.
  • 7高波,段志坚,徐薇,熊思东.固有免疫分子TRIM5α对乙型肝炎病毒复制的影响[J].中国免疫学杂志,2009,25(7):601-605. 被引量:1
  • 8Tissot C,Mechti N.Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression[J].J Biol Chem,1995;270(25):14891-14898.
  • 9Bouazzaoui A,Kreutz M,Eisert V et al.Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages[J].Virology,2006;356(1-2):79-94.
  • 10Singh R,Gaiha G,Werner L et al.Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection[J].J Virol,2011;85(1):208-216.

二级参考文献16

  • 1Reymond A,Meroni G,Fantozzi A et al.The tripartite motif family identifies cell compartments[J].EMBO J,2001;20 (9):2140-2151.
  • 2Ozato K,Shin D M,Chang T H et al.TRIM family proteins and their emerging roles in innate immunity[J].Nat Rev Immunol,2008;8(11):849-860.
  • 3Nisole S,Stoye J P,Saib A.TRIM family proteins:retroviral restriction and antiviral defence[J].Nat Rev Microbiol,2005;3(10):799-808.
  • 4Stremlau M,Owens C M,Perron M J et al.The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys[J].Nature,2004;427(6977):848-853.
  • 5Ganem D,Prince A M.Hepatitis B virus infection-natural history and clinical consequences[J].N Engl J Med,2004;350 (11):1118-1129.
  • 6Seeger C,Mason W S.Hepatitis B virus biology[J].Microbiol Mol Biol Rev,2000;64(1):51-68.
  • 7Yang P L,Althage A,Chung J et al.Hydrodynamic injection of viral DNA:A mouse model of acute hepatitis B virus infection[J].Proc Natl Acad Sci USA,2002;99(21):13825-13830.
  • 8Chiu Y L,Soros V B,Kreisberg J F et al.Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells[J].Nature,2005;435 (7038):108-114.
  • 9Turelli P,Mangeat B,Jost S et al.Inhibition of hepatitis B virus replication by APOBEC3G[J].Science,2004;303 (5689):1829-1829.
  • 10Rosler C,Kock J,Kann M et al.APOBEC-mediated interference with hepadnavirus production[J],Hepatology,2005;42(2):301-309.

同被引文献40

  • 1刘思国,马刚,余兴龙,张茂林,涂长春.猪瘟病毒E2糖蛋白抗原表位的预测、多肽合成及特性研究[J].中国免疫学杂志,2004,20(7):448-450. 被引量:9
  • 2Silva S, Negri M, Henriques M, et al. Candida glabrata, Candida pa- rapsilosis and Candida tropicalis : biology, epidemiology, pathogenicity and antifung'al resistance [ J ]. FEMS Microbiol Rev, 2012, 36 ( 2 ) : 288 - 305.
  • 3PfaUer MA. Antifungal drug resistance : mechanisms, epidemiology, and consequences for treatment [ J]. Am J Med, 2012, 125 ( Suppl 1): S3 - S13.
  • 4Ferrari S, Sanguinetti M, Torelli R, et al. Contribution of CgPDR1- regulated genes in enhanced virulence of azole-resistant Candida glabrata[J/OL]. PLoS One, 2011,6(3) : e17589.
  • 5Vermitsky JP, Earhart KD, Smith WL, et al. Pdrl regulates muhidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies[ J]. Mol Microbiol, 2006, 61 ( 3 ) : 704 - 722.
  • 6Tsai HF, Krol AA, Sarti KE, et al. Candida glabrata PDR1, a tran- scriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants[ J]. Antimicrob Agents Chemother, 2006, 50(4) : 1384 -1392.
  • 7Sanguinetti M, Posteraro B, Fiori B, et al. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance [ J ]. Antimicrob Agents Chemother, 2005, 49 (2) : 668 - 679.
  • 8Song JW, Shin JH, Kee SJ, et al. Expression of CgCDR1, CgCDR2,and CgERG11 in Candida glabrata biofilms formed by bloodstream isolates[J]. Med Mycol, 2009, 47(5) : 545 -548.
  • 9Posteraro B, Sanguinetti M, Fiori B, et al. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata over- expressing efflux pump genes[ J]. J Antimicrob Chemother, 2006, 58 (2) : 458 -461.
  • 10Shin JH, Chae MJ, Song JW, et al. Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia[ J]. J Clin Microbiol, 2007, 45 (8) : 2385 - 2391.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部